Nogapendekin Alfa Inbakicept Side Effects
Applies to nogapendekin alfa inbakicept: intravesical solution.
Side effects include:
The most common (≥15%) adverse reactions, including laboratory test abnormalities, are increased creatinine, dysuria, hematuria, urinary frequency, micturition urgency, urinary tract infection, increased potassium, musculoskeletal pain, chills, pyrexia.
For healthcare professionals
Applies to nogapendekin alfa inbakicept: intravesical solution.
General adverse events
The most common adverse reactions (greater or equal than 15%) were increased creatinine, dysuria, hematuria, urinary frequency, micturition urgency, urinary tract infection, increased potassium, musculoskeletal pain, chills and pyrexia.[Ref]
Metabolic
- Very common (10% or more): Increased creatinine (76%), increased potassium (18%)[Ref]
Genitourinary
- Very common (10% or more): Dysuria (32%), hematuria (32%), urinary frequency (27%), micturition urgency (25%), urinary tract infection (24%), bladder irritation (11%)
- Common (1% to 10%): Nocturia[Ref]
Other
Musculoskeletal
- Very common (10% or more): Musculoskeletal pain (17%)[Ref]
Gastrointestinal
See also:
References
1. (2024) "Product Information. Anktiva (nogapendekin alfa inbakicept)." Altor BioScience, LLC
More about nogapendekin alfa inbakicept
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Nogapendekin alfa inbakicept side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.
